ETFs Boston Scientific Corporation

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 05/12/2025 GMT			After hours 01:00:00
97.52 ^USD	-0.20%		96.46	-1.09%

12-02	Boston Scientific Insider Sold Shares Worth $1,758,189, According to a Recent SEC Filing	MT
12-02	Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S	CI

ETFs positioned on Boston Scientific Corporation

Name	Weight	AuM	Varia. Jan 1.	Investor
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	1.75%	26 M€	+11.73%	-
HAMILTON ENHANCED MULTI-SECTOR COVERED CALL ETF - CAD	0.78%	634 M€	+19.55%	-
HAMILTON ENHANCED U.S. COVERED CALL ETF - CAD HEDGED	0.72%	579 M€	+8.81%	-
HAMILTON ENHANCED U.S. COVERED CALL ETF - USD	0.72%	66 M€	+11.13%	-
VANECK WORLD EQUAL WEIGHT SCREENED UCITS ETF - EUR	0.47%	1,101 M€	+9.18%	-
VANECK MULTI-ASSET GROWTH ALLOCATION UCITS ETF - EUR	0.38%	31 M€	+3.89%	-
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.37%	2 M€	-.--%	-
CSIF (IE) MSCI USA TECH 125 ESG UNIVERSAL BLUE UCITS ETF B - USD	0.35%	0 M€	-.--%	-
AMUNDI S&P 500 ESG - UCITS ETF DR (C) - EUR	0.26%	0 M€	-.--%	-
AMUNDI S&P 500 ESG - UCITS ETF DR HEDGED EUR (C) - EUR	0.26%	0 M€	-.--%	-
NEXT FUNDS S&P 500 SCORED & SCREENED INDEX ETF - JPY	0.22%	5 M€	+8.93%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.22%	0 M€	+0.01%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DAILY HEDGED TO EUR - ACC - HEDGED EUR	0.22%	0 M€	+0.11%	-
SYGNIA ITRIX S&P 500 ETF	0.21%	36,979 M€	+3.24%	-
HSBC MSCI USA QUALITY UCITS ETF - USD	0.19%	322 M€	+12.45%	-

1 2 3

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (64.2%): products used in cardiology surgeries (24.6% of net sales), peripheral surgeries (22.4%), cardiac rhythm management (21.2%), electrophysiology tests (17.7%) and other (14.1%); - endodontic surgery (29.2%): equipment used in endoscopy (55% of net sales), and urology (45%) ; - neuromodulation (6.6%). Net sales are distributed geographically as follows: the United States (61%), Europe/Middle East/Africa (19.3%), Asia/Pacific (16%) and other (3.7%).

Employees

53,000

Sector

Advanced Medical Equipment & Technology

Calendar

02-03 - Q4 2025 Earnings Release (Projected)

More about the company